Sotera Health Company
SHC
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $5.4B
$18.90
▼ -0.68%
P/E
66.71
Mkt Cap
$5.4B
52-Wk Range
$13.09–$19.85
52-Week Range
$13.09 - $19.85
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 18.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Above-average volatility (beta 1.8).
Growth
Strong growth ahead
Value
Fairly valued vs sector peers
Momentum
Hot
+21.0% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying SHC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 6, 2026
Reported EPS of $0.26 vs $0.24 consensus (+8.8% surprise). Revenue of $321.4M vs $309.7M expected (+3.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+8.8%
Revenue trend · last 2Q
—
+9%
Q1 26
Q2 26
$280.0M
$321.4M
Margins · last 2Q
Gross
55.4%
Operating
33.2%
Profit
16.7%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Barclays · Aug 7, 2026
vs Industry
How SHC stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.